Assessment of the Effects of a High Amikacin Dose on Plasma Peak Concentration in Critically Ill Children.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 395, doi. 10.1007/s40272-021-00456-0
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2021 AND VI 23 AND IP 4
Results: 9
1
2
Navigating the Regulatory Landscape to Develop Pediatric Oncology Drugs: Expert Opinion Recommendations.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 381, doi. 10.1007/s40272-021-00455-1
- By:
- Publication type:
- Article
3
Evaluating and Mitigating Risk of Acute Kidney Injury with the Combination of Vancomycin and Piperacillin-Tazobactam in Children.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 373, doi. 10.1007/s40272-021-00458-y
- By:
- Publication type:
- Article
4
An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 331, doi. 10.1007/s40272-021-00457-z
- By:
- Publication type:
- Article
5
Lidocaine Infusions for Pain Management in Pediatrics.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 349, doi. 10.1007/s40272-021-00454-2
- By:
- Publication type:
- Article
6
Viloxazine: Pediatric First Approval.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 403, doi. 10.1007/s40272-021-00453-3
- By:
- Publication type:
- Article
7
Mirabegron: Pediatric First Approval.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 411, doi. 10.1007/s40272-021-00452-4
- By:
- Publication type:
- Article
8
Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 317, doi. 10.1007/s40272-021-00451-5
- By:
- Publication type:
- Article
9
Pain Management in Children: NSAID Use in the Perioperative and Emergency Department Settings.
- Published in:
- Pediatric Drugs, 2021, v. 23, n. 4, p. 361, doi. 10.1007/s40272-021-00449-z
- By:
- Publication type:
- Article